Abstract
Invention relates to medicine and particularly to methods for evalutation of efficacy of treatment of hepatitis C. The method provides for determination of serum level of cytokeratin‑18 neoepitope. If the serum level is 129 U/L or lower the efficacy of the treatment is established.
Translated title of the contribution | Ārstēšanas efektivitātes noteikšanas paņēmiens hroniska vīrushepatīta C slimniekiem remisijas stadijā pēc 24-48 nedēļu ārstēšanas |
---|---|
Original language | Latvian |
Patent number | 14923 |
IPC | G01N33/53 |
Priority date | 28/05/14 |
Filing date | 28/05/14 |
Publication status | Published - 20 Jan 2015 |
Keywords*
- methods for evalutation of efficacy of treatment of hepatitis C
Field of Science*
- 3.2 Clinical medicine
Patent expiration date
- 01.12.2020